Colgate-Palmolive reported second-quarter 2026 earnings and sales that beat analyst expectations, driven by higher organic sales and strategic gains. Base Business earnings reached 99 cents per share, up 8% from a year ago and surpassing the Zacks Consensus Estimate of 95 cents. Net sales rose 4.9% to $5.36 billion, edging past the $5.35 billion consensus, with organic sales growth of 2.4% supported by a 0.8% volume increase and 1.6% pricing growth. Gross profit margin expanded 140 basis points to 61.5%, and the company raised its full-year Base Business earnings growth forecast to mid-single digits from low- to mid-single digits, while now expecting gross margin to be roughly flat rather than declining. Regional performance was mixed, with Latin America leading at 13.7% net sales growth, while North America sales fell 3%.
Colgate-Palmolive CompanyQ2 earnings and sales beat estimates, margins expanded, and full-year guidance raised.
Freshpet Inc
MEDIFAST INC
United Natural Foods Inc